Myriad settles lawsuits over cancer gene testing patents

February 3, 2015 – Myriad Genetics has settled its patent infringement lawsuit with Ambry Genetics and Counsyl with respect to Myriad’s patents covering BRCA cancer gene testing. The cases were captioned University of Utah Research Foundation et al v. Ambry Genetics and Counsyl, Inc. v. Myriad Genetics, Inc., 13-cv-00640 and 14-cv-00150, respectively, both in the District of Utah, Central Division.

By: Christopher J. Stankus

View Attachment (PDF)